The Department of Defense Gulf War Illness New Investigator Award supports new investigators in the field of Gulf War Illness research. This award encourages innovative research ideas and proof-of-concept studies to advance the understanding and treatment of Gulf War Illness. Eligible applicants include transitioning postdoctoral fellows, early-career investigators, and new Gulf War Illness researchers. The focus is on identifying objective measures, understanding pathobiology, and developing interventions for Gulf War Illness. Collaborations and preliminary data are encouraged but not required. Research involving human subjects is permitted, excluding clinical trials. Applications proposing biomarker research must demonstrate specificity to Gulf-related exposures. Applications focusing on psychiatric disease as the primary cause of Gulf War Illness will not be funded.
Opportunity ID: 283829
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-16-GWIRP-NIA |
| Funding Opportunity Title: | DoD Gulf War Illness New Investigator Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 13, 2016 |
| Last Updated Date: | Jul 15, 2016 |
| Original Closing Date for Applications: | Oct 20, 2016 |
| Current Closing Date for Applications: | Oct 20, 2016 |
| Archive Date: | Nov 19, 2016 |
| Estimated Total Program Funding: | $2,400,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The GWIRP New Investigator Award mechanism was first offered in FY14. Since then, 33 New Investigator Award applications have been received, and 12 have been recommended for funding.The intent of the GWIRP New Investigator Award is to support investigators new to the field of GWI research at different stages of career development. This award enables such investigators to compete for funding separately from investigators with established programs of GWI research. Previous experience in GWI research is allowed, but not required. However, Principal Investigators (PIs) with a limited background in GWI research are strongly encouraged to strengthen their applications through collaboration with investigators who are experienced in GWI research and/or possess other relevant expertise. It is the PI’s responsibility to describe how the collaboration(s) will augment his/her ability to address the research question.All applicants for the New Investigator Award must meet specific eligibility criteria under one of the following categories, as described in Section I.D., Eligibility Information. Transitioning Postdoctoral Fellow Early-Career Investigator New GWI ResearcherThe New Investigator Award is designed to promote new ideas in GWI research and establish proof-of-principle for further development in future studies. Basic through clinical research is allowed under this award mechanism. The types of studies that will be supported include those aimed at identification of objective measures (e.g., biomarkers) to distinguish healthy Veterans from those with GWI, studies to improve the understanding of the pathobiology underlying symptoms, and preclinical development of interventions for GWI. Applications are not required to include preliminary data; however, preliminary data may be used to support the objectives of proposed project. These data are not required to have come from the GWI research field. Applications not supported by preliminary data should be based on sound scientific rationale and may reflect clinical observations or discoveries made in other illnesses. Regardless of the approach, the focus should be clearly on Veterans with GWI. It is the responsibility of the PI to clearly and explicitly articulate the project’s potential impact on GWI.Applications Proposing Biomarker Research: Applicants must present a rationale for why the proposed markers would be specific for GW-related exposures and not induced by independent factors or events unrelated to Gulf War deployment. Investigation involving derivation of markers from animal models does not address the intent of the biomarker focus area under this award.Research involving human subjects is permitted under this Program Announcement/Funding Opportunity but is restricted to studies without clinical trials. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For more information about distinguishing clinical trials from clinical research, a Human Subject Resource Document is provided at https://cdmrp.org/ Program_Announcements_and_Forms/. PIs interested in applying for funding for a clinical trial should use the FY16 GWIRP Treatment Evaluation Award mechanism. For information about that mechanism, see http://cdmrp.army.mil/funding/gwirp.shtml. Retrospective studies or other non-interventional study designs are acceptable under the New Investigator Award.Studies whose principal focus is on psychiatric disease or psychological stress as the primary cause of GWI will not be funded under this Program Announcement/Funding Opportunity. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The date for submission of a preapplication is being extended until October, 6, 2016. | Jul 15, 2016 | |
| Jul 15, 2016 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-16-GWIRP-NIA |
| Funding Opportunity Title: | DoD Gulf War Illness New Investigator Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 13, 2016 |
| Last Updated Date: | Jul 15, 2016 |
| Original Closing Date for Applications: | Oct 20, 2016 |
| Current Closing Date for Applications: | Oct 20, 2016 |
| Archive Date: | Nov 19, 2016 |
| Estimated Total Program Funding: | $2,400,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The GWIRP New Investigator Award mechanism was first offered in FY14. Since then, 33 New Investigator Award applications have been received, and 12 have been recommended for funding.The intent of the GWIRP New Investigator Award is to support investigators new to the field of GWI research at different stages of career development. This award enables such investigators to compete for funding separately from investigators with established programs of GWI research. Previous experience in GWI research is allowed, but not required. However, Principal Investigators (PIs) with a limited background in GWI research are strongly encouraged to strengthen their applications through collaboration with investigators who are experienced in GWI research and/or possess other relevant expertise. It is the PI’s responsibility to describe how the collaboration(s) will augment his/her ability to address the research question.All applicants for the New Investigator Award must meet specific eligibility criteria under one of the following categories, as described in Section I.D., Eligibility Information. Transitioning Postdoctoral Fellow Early-Career Investigator New GWI ResearcherThe New Investigator Award is designed to promote new ideas in GWI research and establish proof-of-principle for further development in future studies. Basic through clinical research is allowed under this award mechanism. The types of studies that will be supported include those aimed at identification of objective measures (e.g., biomarkers) to distinguish healthy Veterans from those with GWI, studies to improve the understanding of the pathobiology underlying symptoms, and preclinical development of interventions for GWI. Applications are not required to include preliminary data; however, preliminary data may be used to support the objectives of proposed project. These data are not required to have come from the GWI research field. Applications not supported by preliminary data should be based on sound scientific rationale and may reflect clinical observations or discoveries made in other illnesses. Regardless of the approach, the focus should be clearly on Veterans with GWI. It is the responsibility of the PI to clearly and explicitly articulate the project’s potential impact on GWI.Applications Proposing Biomarker Research: Applicants must present a rationale for why the proposed markers would be specific for GW-related exposures and not induced by independent factors or events unrelated to Gulf War deployment. Investigation involving derivation of markers from animal models does not address the intent of the biomarker focus area under this award.Research involving human subjects is permitted under this Program Announcement/Funding Opportunity but is restricted to studies without clinical trials. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For more information about distinguishing clinical trials from clinical research, a Human Subject Resource Document is provided at https://cdmrp.org/ Program_Announcements_and_Forms/. PIs interested in applying for funding for a clinical trial should use the FY16 GWIRP Treatment Evaluation Award mechanism. For information about that mechanism, see http://cdmrp.army.mil/funding/gwirp.shtml. Retrospective studies or other non-interventional study designs are acceptable under the New Investigator Award.Studies whose principal focus is on psychiatric disease or psychological stress as the primary cause of GWI will not be funded under this Program Announcement/Funding Opportunity. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@eBRAP.org |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-16-GWIRP-NIA |
| Funding Opportunity Title: | DoD Gulf War Illness New Investigator Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 15, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Oct 20, 2016 |
| Archive Date: | Nov 19, 2016 |
| Estimated Total Program Funding: | $2,400,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The GWIRP New Investigator Award mechanism was first offered in FY14. Since then, 33 New Investigator Award applications have been received, and 12 have been recommended for funding. The intent of the GWIRP New Investigator Award is to support investigators new to the field of GWI research at different stages of career development. This award enables such investigators to compete for funding separately from investigators with established programs of GWI research. Previous experience in GWI research is allowed, but not required. However, Principal Investigators (PIs) with a limited background in GWI research are strongly encouraged to strengthen their applications through collaboration with investigators who are experienced in GWI research and/or possess other relevant expertise. It is the PI’s responsibility to describe how the collaboration(s) will augment his/her ability to address the research question. All applicants for the New Investigator Award must meet specific eligibility criteria under one of the following categories, as described in Section I.D., Eligibility Information. Transitioning Postdoctoral Fellow Early-Career Investigator New GWI Researcher The New Investigator Award is designed to promote new ideas in GWI research and establish proof-of-principle for further development in future studies. Basic through clinical research is allowed under this award mechanism. The types of studies that will be supported include those aimed at identification of objective measures (e.g., biomarkers) to distinguish healthy Veterans from those with GWI, studies to improve the understanding of the pathobiology underlying symptoms, and preclinical development of interventions for GWI. Applications are not required to include preliminary data; however, preliminary data may be used to support the objectives of proposed project. These data are not required to have come from the GWI research field. Applications not supported by preliminary data should be based on sound scientific rationale and may reflect clinical observations or discoveries made in other illnesses. Regardless of the approach, the focus should be clearly on Veterans with GWI. It is the responsibility of the PI to clearly and explicitly articulate the project’s potential impact on GWI. Applications Proposing Biomarker Research: Applicants must present a rationale for why the proposed markers would be specific for GW-related exposures and not induced by independent factors or events unrelated to Gulf War deployment. Investigation involving derivation of markers from animal models does not address the intent of the biomarker focus area under this award. Research involving human subjects is permitted under this Program Announcement/Funding Opportunity but is restricted to studies without clinical trials. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For more information about distinguishing clinical trials from clinical research, a Human Subject Resource Document is provided at https://cdmrp.org/ Program_Announcements_and_Forms/. PIs interested in applying for funding for a clinical trial should use the FY16 GWIRP Treatment Evaluation Award mechanism. For information about that mechanism, see http://cdmrp.army.mil/funding/gwirp.shtml. Retrospective studies or other non-interventional study designs are acceptable under the New Investigator Award. Studies whose principal focus is on psychiatric disease or psychological stress as the primary cause of GWI will not be funded under this Program Announcement/Funding Opportunity. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@eBRAP.org |
Related Documents
Folder 283829 Full Announcement-FY16 GWIRP NIA -> GWIRP_FY16_NIA2 PA_GG.pdf
Folder 283829 Full Announcement-FY16 GWIRP NIA -> gwirp_fy16_nia_statement_of_independence.pdf
Folder 283829 Full Announcement-FY16 GWIRP NIA -> gwirp_fy16_nia_statement_of_eligibility.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk 301-682-5507 Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00223489 | May 13, 2016 | Oct 20, 2016 | View |
Package 1
Mandatory forms
283829 RR_SF424_2_0-2.0.pdf
283829 RR_Budget_1_3-1.3.pdf
283829 RR_KeyPersonExpanded_2_0-2.0.pdf
283829 PerformanceSite_2_0-2.0.pdf
Optional forms
283829 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
